Articles |

Etiology and Pathogenesis of Primary Pulmonary Hypertension : A Perspective FREE TO VIEW

Alfred P. Fishman
Author and Funding Information

From the Department of Rehabilitation Medicine, University of Pennsylvania, Philadelphia

Alfred P. Fishman, MD, FCCP, University of Pennsylvania School of Medicine, 1319 Blockley Hall, 418 Guardian Dr, Philadelphia, PA 19104-6021

1998 by the American College of Chest Physicians

Chest. 1998;114(3_Supplement):242S-247S. doi:10.1378/chest.114.3_Supplement.242S
Text Size: A A A
Published online


In recent years, considerable advances have been made in treating primary pulmonary hypertension (PPH). These have provided a series of therapeutic options, ranging from the oral administration of calcium channel blockers to the continuous infusion of prostacyclin and/or lung transplantation. These therapeutic advances have highlighted the need for the better understanding of etiology and pathogenesis. Among the key uncertainties, the following are defined as leading uncertainties: (1) the nature of the initiating lesion; (2) the shared pathogenetic mechanisms that culminate in the pathologic lesions of PPH; (3) the molecular genetic bases for familial PPH and for susceptibility to PPH; (4) understanding of the obliterative-proliferative occlusive process in the small muscular pulmonary arteries; and (5) redefinition of "primary" and "secondary," ie, a revised nomenclature of pulmonary hypertension. A revised classification based on etiology is presented.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543